Straube Barry M
Office of Clinical Standards and Quality, Centers for Medicare and Medicaid Services (CMS), Baltimore, Maryland, USA.
Health Aff (Millwood). 2005 Jan-Jun;Suppl Web Exclusives:W5-314-W5-316. doi: 10.1377/hlthaff.w5.314.
The Medicare coverage decision process can affect the availability and use of new technologies. The Centers for Medicare and Medicaid Services (CMS) has recently made advances in making its coverage decision process speedier, predictable, and more transparent. The CMS recently issued draft Coverage with Evidence Development (CED) guidance to assure that Medicare beneficiaries have access to new technologies through expanded coverage criteria, while gathering information that can be helpful to the doctors who care for them. The CMS continues these efforts with the goal of improving the evidence used for high-quality care, while avoiding unnecessary risks and costs.
医疗保险覆盖范围决策过程会影响新技术的可及性和使用。医疗保险和医疗补助服务中心（CMS）最近在加快其覆盖范围决策过程、提高可预测性和增强透明度方面取得了进展。CMS最近发布了“有证据支持的发展性覆盖”（CED）指南草案，以确保医疗保险受益人通过扩大覆盖标准能够使用新技术，同时收集对照顾他们的医生可能有用的信息。CMS继续这些努力，目标是改进用于高质量医疗的证据，同时避免不必要的风险和成本。
